Alterity Therapeutics
ATHE
29 hedge funds and large institutions have $3.36M invested in Alterity Therapeutics in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
139% more call options, than puts
Call options by funds: $6.4M | Put options by funds: $2.67M
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
26% more funds holding
Funds holding: 23 → 29 (+6)
39% less capital invested
Capital invested by funds: $5.54M → $3.36M (-$2.18M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.32M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.1M |
| 3 |
Barclays
London,
United Kingdom
|
+$1.07M |
| 4 |
AG
Aperio Group
Sausalito,
California
|
+$996K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$657K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FC
FIC Capital
New York
|
-$533K |
| 2 |
Jane Street
New York
|
-$421K |
| 3 |
CAM
Columbia Asset Management
Ann Arbor,
Michigan
|
-$366K |
| 4 |
Millennium Management
New York
|
-$277K |
| 5 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$194K |
ATHE Hedge Fund Activity: Q1 2014 in Review
29 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q1 2014, worth a combined $3.36M — down 39% from $5.54M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ATHE positions and 7 closed out — a net gain of 6 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.32M. The largest seller was FIC Capital, exiting entirely with an estimated $533K sold.
- 29 institutional investors held Alterity Therapeutics (ATHE) as of Q1 2014, up from 23 in Q4 2013.
- Funds reported $3.36M of Alterity Therapeutics stock for Q1 2014, down 39% quarter-over-quarter.
- 13 funds opened new Alterity Therapeutics positions in Q1 2014 and 7 closed out, a net change of +6 holders.
- The largest Alterity Therapeutics buyer in Q1 2014 was Susquehanna International Group, an estimated $2.32M added.
- The largest Alterity Therapeutics seller in Q1 2014 was FIC Capital, an estimated $533K sold.
Based on aggregated 13F filings for Q1 2014.